HLB Therapeutics Co.,Ltd. (KOSDAQ:115450)

HLB Therapeutics Revenue

HLB Therapeutics had revenue of 16.06B KRW in the quarter ending September 30, 2025, with 14.32% growth. This brings the company's revenue in the last twelve months to 63.25B, up 16.82% year-over-year. In the year 2024, HLB Therapeutics had annual revenue of 54.93B with 4.45% growth.

• Revenue (ttm): 63.25B
• Revenue Growth: +16.82%
• P/S Ratio: 3.82
• Revenue / Employee: 1.29B
• Employees: 49
• Market Cap: 241.80B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	54.93B	2.34B	4.45%
Dec 31, 2023	52.59B	10.19B	24.03%
Dec 31, 2022	42.40B	-1.18B	-2.72%
Dec 31, 2021	43.59B	656.63M	1.53%
Dec 31, 2020	42.93B	-16.04B	-27.20%